Carillon Tower Advisers released its second-quarter 2025 investor letter, noting the turbulent period in equity markets. Small-cap stocks saw a rebound, with the Russell 2000® Growth Index leading with an 11.96% gain. Check out the fund’s top five holdings for 2025’s best picks.

Cellebrite DI Ltd. (NASDAQ:CLBT), a software company, was highlighted in the Carillon Eagle Small Cap Growth Fund’s Q2 2025 investor letter. Despite a temporary setback due to leadership changes, the company remains focused on providing smartphone data solutions for law enforcement investigators.

Cellebrite DI Ltd. (NASDAQ:CLBT) reported a revenue of $113.3 million in Q2 2025, driven by subscription revenue growth of 21%. While the company shows potential, other AI stocks may offer greater upside potential. For an undervalued AI stock with significant growth potential, check out our free report on the best short-term AI stock.

Read more at Yahoo Finance: Cellebrite (CLBT) Fell Due to Below-Expected Outlook, but Core Trends Persist